TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
32.32
-0.94 (-2.83%)
Nov 7, 2025, 10:58 AM EST - Market open
TG Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts that cover TG Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $48.2, which forecasts a 49.13% increase in the stock price over the next year. The lowest target is $22 and the highest is $60.
Price Target: $48.2 (+49.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TG Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $46 → $49 | Buy | Maintains | $46 → $49 | +51.61% | Nov 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +85.64% | Oct 6, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $53 → $55 | Strong Buy | Maintains | $53 → $55 | +70.17% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +70.17% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +70.17% | Jan 15, 2025 |
Financial Forecast
Revenue This Year
599.81M
from 329.00M
Increased by 82.31%
Revenue Next Year
894.01M
from 599.81M
Increased by 49.05%
EPS This Year
0.77
from 0.15
Increased by 414.25%
EPS Next Year
1.91
from 0.77
Increased by 147.93%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 621.6M | 973.4M | |||
| Avg | 599.8M | 894.0M | |||
| Low | 571.1M | 820.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 88.9% | 62.3% | |||
| Avg | 82.3% | 49.0% | |||
| Low | 73.6% | 36.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.02 | 2.63 | |||
| Avg | 0.77 | 1.91 | |||
| Low | 0.52 | 1.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 579.0% | 240.3% | |||
| Avg | 414.3% | 147.9% | |||
| Low | 246.3% | 71.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.